Summary
The interaction of chlorpromazine, dl-propranolol, and imipramine with isolated α1-acid glycoprotein is characterized by relatively high association constants and only one binding site per protein molecule. The mutual displacement between the three drugs indicates that all three compounds are bound to the same binding site. Several other basic drugs from different pharmacological and chemical classes also displace chlorpromazine, dl-propranolol, and imipramine with potencies, one would predict from their association constants or from the degree of their plasma binding in humans. It is concluded that displacement phenomena like those observed in this study in vitro are likely to occur also in vivo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Borga O, Azarnoff DL, Plym Forshell G, Sjöqvist F (1969) Plasma protein binding of tricyclic antidepressants in man. Biochem Pharmacol 18:2135–2143
Brinkschulte M, Breyer-Pfaff U (1980) The contribution of α1-acid glycoprotein, lipoproteins, and albumin to the plasma binding of perazine, amitriptyline, and nortriptyline in healthy man. Naunyn-Schmiedeberg's Arch Pharmacol 314:61–66
Brooks MH, Malloy JP, Bartelloni PJ, Sheehy TW, Barry KG (1969) Quinine, pyrimethamine, and sulphortodimethoxine: clinical response, plasma levels, and urinary excretion during the initial attack of naturally acquired falciparum malaria. Clin Pharmacol Ther 10:85–91
De Leve LD, Piafsky KM (1981) Clinical significance of plasma binding of basic drugs. TIPS 283–284
El-Gamal S, Wollert U, Müller WE (1982) Optical studies on the specific interaction of dipyridamole with α1-acid glycoprotein. J Pharm Pharmacol 34:152–157
El-Gamal S, Wollert U, Müller WE (1983) The binding of several phenothiazine neuroleptics to a common binding site of α1-acid glycoprotein (orosomucoid). J Pharm Sci (in press)
Fehske KJ, Müller WE, Wollert U (1981) The location of drug binding sites in human serum albumin. Biochem Pharmacol 30:687–692
Fremdstad D, Bergerud K, Haffner JFW, Lunde PKM (1976) Increased plasma binding of quinidine after surgery. A preliminary report. Eur J Clin Pharmacol 10:441–444
Ganguly M, Westphal U (1968) Steroid-protein interactions. XVII. Influence of solvent environment on interaction between human α1-acid glycoprotein and progesterone. J Biol Chem 243:6130–6139
Glasson S, Zini R, D'Athis P, Tillement JP, Boissier JR (1980) The distribution of bound propranolol between the different human serum proteins. Mol Pharmacol 17:187–191
Jähnchen E, Bechtold H, Kasper W, Kersting F, Just H, Meinertz T (1979) Lorcainide. I. Saturable presystemic elimination. Clin Pharmacol Ther 26:187–195
Kerkay J, Westphal U (1969) Steroid-protein interactions. XXI. Metal ion inhibition of association between progesterone and 172-5 glycoprotein. Arch Biochem Biophys 129:480–489
Kopitar Z, Weisenberger H (1971) Spezifische Bindung von Dipyridamol an ein menschliches Serumprotein. Arzneimittelforschung 21: 859–862
Kornguth ML, Hutchins LG, Eichelman BS (1981) Binding of psychotropic drugs to isolated 172-6 glycoprotein. Biochem Pharmacol 30:2435–2441
Kragh-Hansen U (1981) Molecular aspects of ligand binding to serum albumin. Pharmacol Rev 33:17–53
Kute T, Westphal U (1971) Chemical modification of α1-acid glycoprotein for characterization of the progesterone binding site. Biochem Biophys Acta 420:195–213
Lima JJ, Boudoulas H, Blanford M (1981) Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics. J Pharmacol Exp Ther 219:741–747
Müller WE, Wollert U (1979) Human serum albumin as a “silent receptor” for drugs and endogenous substances. Pharmacology 19:59–67
Piafsky KM (1980) Disease-induced changes in the plasma binding of basic drugs. Clin Pharmacokinet 5:246–262
Piafsky KM, Knoppert D (1978) Binding of local anesthetics to α1-acid glycoprotein. Clin Res 26:836A
Piafsky KM, Borga O, Odar-Cederlöf I, Johansson C, Sjöqvist F (1978) Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma α1-acid glycoprotein. N Engl J Med 299:1435–1438
Romach MK, Piafsky KM, Abel JG, Khouw V, Sellers EM (1981) Methadone binding to orosomucoid (α1-acid glycoprotein): determinant of free fraction in plasma. Clin Pharmacol Ther 29: 211–217
Routledge PA, Shand DG, Barchowsky A, Wagner G, Stargel WW (1981) Relationship between α1-acid glycoprotein and lidocaine disposition in myocardial infarction. Clin Pharmacol Ther 30: 154–157
Sager G, Nilsen OG, Jacobsen S (1979) Variable binding of propranolol in human serum. Biochem Pharmacol 28:905–911
Schley J, Nündel M, Siegert M, Riedel E, Müller-Oerlinghausen B (1980) High affinity binding of perazine and desmethylperazine to human α1-acid glycoprotein. Pharmacopsychiat 13:144–145
Tucker GT, Mather LE (1979) Clinical pharmacokinetics of local anaesthetics. Clin Pharmacokin 4:241–278
Author information
Authors and Affiliations
Additional information
This study was supported by a grant of the Deutsche Forschungsgemeinschaft
Rights and permissions
About this article
Cite this article
Müller, W.E., Stillbauer, A.E. Characterization of a common binding site for basic drugs on human α2-acid glycoprotein (orosomucoid). Naunyn-Schmiedeberg's Arch. Pharmacol. 322, 170–173 (1983). https://doi.org/10.1007/BF00512392
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00512392